Skip to Main Content

Author Details

Larry Norton
Memorial Sloan Kettering Cancer Center
1976
440
109
PMIDPaper TitleJournal TitlePublished Year
37090606Functional transcriptional signatures for tumor-type-agnostic phenotype prediction.bioRxiv2024
37768520Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores.Breast Cancer Res Treat2024
37090606Functional transcriptional signatures for tumor-type-agnostic phenotype prediction.bioRxiv2024
37768520Impact of reactive changes on multigene testing: histopathologic analysis of low-grade breast cancers with high-risk 21-gene recurrence scores.Breast Cancer Res Treat2024
36414432Targeting stressor-induced dysfunctions in protein-protein interaction networks via epichaperomes.Trends Pharmacol Sci2023
36414432Targeting stressor-induced dysfunctions in protein-protein interaction networks via epichaperomes.Trends Pharmacol Sci2023
38030619Gene interaction network analysis in multiple myeloma detects complex immune dysregulation associated with shorter survival.Blood Cancer J2023
37561983Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors.JCO Precis Oncol2023
37414212New Frontiers in the Role of Locoregional Therapies in Breast Cancer: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel.J Vasc Interv Radiol2023
36585450Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.Nat Cancer2023
37329617Geometric graph neural networks on multi-omics data to predict cancer survival outcomes.Comput Biol Med2023
37221256International research to address the challenges of metastatic breast cancer: the AURORA Program (BIG 14-01).NPJ Breast Cancer2023
36843667Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and Management.Ann Glob Health2023
37561983Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors.JCO Precis Oncol2023
38030619Gene interaction network analysis in multiple myeloma detects complex immune dysregulation associated with shorter survival.Blood Cancer J2023
37221256International research to address the challenges of metastatic breast cancer: the AURORA Program (BIG 14-01).NPJ Breast Cancer2023
37414212New Frontiers in the Role of Locoregional Therapies in Breast Cancer: Proceedings from the Society of Interventional Radiology Foundation Research Consensus Panel.J Vasc Interv Radiol2023
37329617Geometric graph neural networks on multi-omics data to predict cancer survival outcomes.Comput Biol Med2023
36585450Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.Nat Cancer2023
36843667Global Oncology Medical Diplomacy Working Group Inaugural Meeting: Defining Worldwide Barriers to Germline Genomics in Cancer Prevention and Management.Ann Glob Health2023
34599282The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.Mod Pathol2022
35902432Escalating de-escalation in breast cancer treatment.Breast Cancer Res Treat2022
35953528Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapy.NPJ Breast Cancer2022
35440655Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/- trastuzumab in patients with breast cancer brain metastases.NPJ Breast Cancer2022
35319017Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab.NPJ Breast Cancer2022
35064104Mobile mammography in New York City: analysis of 32,350 women utilizing a screening mammogram program.NPJ Breast Cancer2022
35193955Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer.Proc Natl Acad Sci U S A2022
34599282The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.Mod Pathol2022
35177701Bone mineral density in women newly diagnosed with breast cancer: a prospective cohort study.NPJ Breast Cancer2022
35440655Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/- trastuzumab in patients with breast cancer brain metastases.NPJ Breast Cancer2022
35902432Escalating de-escalation in breast cancer treatment.Breast Cancer Res Treat2022
35953528Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapy.NPJ Breast Cancer2022
35319017Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab.NPJ Breast Cancer2022
35177701Bone mineral density in women newly diagnosed with breast cancer: a prospective cohort study.NPJ Breast Cancer2022
35064104Mobile mammography in New York City: analysis of 32,350 women utilizing a screening mammogram program.NPJ Breast Cancer2022
35193955Redox signaling by glutathione peroxidase 2 links vascular modulation to metabolic plasticity of breast cancer.Proc Natl Acad Sci U S A2022
33021035The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas.Mol Oncol2021
34294707Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma.NPJ Breast Cancer2021
34117028In Memoriam: José Baselga's Journey in Cancer Medicine.Clin Cancer Res2021
33449096Accuracy of Magnetic Resonance Imaging-Guided Biopsy to Verify Breast Cancer Pathologic Complete Response After Neoadjuvant Chemotherapy: A Nonrandomized Controlled Trial.JAMA Netw Open2021
34031428Anti-tumor effects of an ID antagonist with no observed acquired resistance.NPJ Breast Cancer2021
33863915TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer.NPJ Breast Cancer2021
33021035The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas.Mol Oncol2021
33332193Comparative Effectiveness Research Needs to Consider Optimal Dosing and Scheduling.J Clin Oncol2021
34819508Geometric network analysis provides prognostic information in patients with high grade serous carcinoma of the ovary treated with immune checkpoint inhibitors.NPJ Genom Med2021
34645798Clonal hematopoiesis is associated with risk of severe Covid-19.Nat Commun2021
34416159The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysis.Lancet Oncol2021
33863915TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer.NPJ Breast Cancer2021
34645798Clonal hematopoiesis is associated with risk of severe Covid-19.Nat Commun2021
34819508Geometric network analysis provides prognostic information in patients with high grade serous carcinoma of the ovary treated with immune checkpoint inhibitors.NPJ Genom Med2021
  • 1 - 50 of 880

Recommended Authors

Leuven Cancer Institute and University Hospitals Leuven
Career Start Year 2015
Number of shared co-authors 19
Merck & Co., Inc.
Career Start Year 2011
Number of shared co-authors 8
University of Milano
Career Start Year 2008
Number of shared co-authors 6
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 6
The Ottawa Hospital Cancer Centre
Career Start Year 2006
Number of shared co-authors 0
Mater Misericordiae University Hospital
Career Start Year 2006
Number of shared co-authors 10
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 17
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 20
Princess Margaret Cancer Centre
Career Start Year 2003
Number of shared co-authors 9
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 27
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 24
Vanderbilt University Medical Center
Career Start Year 2000
Number of shared co-authors 20
New York Presbyterian Hospital
Career Start Year 1997
Number of shared co-authors 8
Cancer Research Center of Hawaii: University of Hawai'i Cancer Center.
Career Start Year 1995
Number of shared co-authors 14
University of Groningen, University Medical Center Groningen
Career Start Year 1995
Number of shared co-authors 6
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 2
Institute of Cancer and Genomic Sciences, The University of Birmingham
Career Start Year 1993
Number of shared co-authors 8
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 17
The University of Texas MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 11
Merck & Co., Inc.
Career Start Year 1991
Number of shared co-authors 5
University of Texas MD Anderson Cancer Center
Career Start Year 1990
Number of shared co-authors 27
Erasmus Medical Center
Career Start Year 1990
Number of shared co-authors 22
12 University College London Hospitals National Health Service Foundation Trust
Career Start Year 1989
Number of shared co-authors 3
GZA Ziekenhuizen Campus Sint-Augustinus, University of Antwerp
Career Start Year 1988
Number of shared co-authors 13
National and Kapodistrian University of Athens
Career Start Year 1987
Number of shared co-authors 3
IRCCS Humanitas Research Hospital
Career Start Year 1987
Number of shared co-authors 8
Leeds Teaching Hospitals NHS Trust, University of Leeds
Career Start Year 1986
Number of shared co-authors 7
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 10
University of Bern
Career Start Year 1985
Number of shared co-authors 7
David Geffen School of Medicine at University of California Los Angeles
Career Start Year 1984
Number of shared co-authors 13

Collaborators

Memorial Sloan Kettering Cancer Center, USA American Society of Clinical Oncology
Co-authored papers 139
Memorial Sloan-Kettering Cancer Center
Co-authored papers 44
Memorial Sloan Kettering Cancer Center
Co-authored papers 40
Memorial Sloan Kettering Cancer Center
Co-authored papers 36
Dana-Farber Cancer Institute
Co-authored papers 34
MD Anderson Cancer Center
Co-authored papers 31
Co-authored papers 28
Memorial Sloan Kettering Cancer Center
Co-authored papers 26
University of Bern
Co-authored papers 25
University of Basel
Co-authored papers 24
Instituto Do Cancer Do Estado de Sao Paulo
Co-authored papers 18
Memorial Sloan Kettering Cancer Center
Co-authored papers 15
Memorial Sloan Kettering Cancer Center
Co-authored papers 15
Monash University
Co-authored papers 12
Co-authored papers 12
Mayo Clinic
Co-authored papers 11
Co-authored papers 10
Co-authored papers 10
Helen Diller Family Comprehensive Cancer Center
Co-authored papers 10
Co-authored papers 9
Co-authored papers 9
Memorial Sloan Kettering Cancer Center
Co-authored papers 9
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Co-authored papers 9
Brown University
Co-authored papers 9
Champalimaud Clinical Center/Champalimaud Foundation
Co-authored papers 9
Co-authored papers 9
Co-authored papers 8
Duke University Research Institute
Co-authored papers 7
Memorial Sloan Kettering Cancer Center
Co-authored papers 7
UCL Great Ormond Street Institute of Child Health, University College London
Co-authored papers 7